Skip to contentB
Bausch Health Companies Inc.
B
BHCBausch Health Companies Inc. Q3 2021 · 10-Q
Revenue$2.11B$2.11B−1.3% vs Q3 2020 Net Income$188.00M$188.00M+164.8% vs Q3 2020 EPS Diluted$0.52$0.52+160.0% vs Q3 2020 Operating Income$574,000,000+24.8% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bausch Health Companies Inc. · CIK 885590 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$501,000,000+186.3% Margins · derivedOperating margin27.2%+5.7 pt vs Q3 2020
Net margin8.9%+5.6 pt vs Q3 2020
ended Sep 30, 2021 · filed Nov 2, 2021 · 33 d after period end